Elevate Health vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Hers scores higher on our rubric, 7.3/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Hers - our pick of these two →or find your match

Hers beats Elevate Health overall, scoring 7.3/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Elevate Health is from $233/mo; Hers is $188 first month, then $298/mo. Choose Elevate Health for users who want financing options and free lab work with their glp-1 program. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.

A side-by-side look at Elevate Health and Hers to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Elevate Health

#39 of 54

7.2/10

Affordable compounded GLP-1 provider with financing options and complimentary lab work for qualifying patients.

Visit Elevate Health

Higher Rated

Hers

#30 of 54

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.

Visit Hers

Feature	Elevate Health	Hers
Why each one	Includes free blood work and buy-now-pay-later financing (Affirm, Klarna, Afterpay), making GLP-1 accessible for patients who can't pay upfront.	A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options.
Our Score	7.2/10	7.3/10
Headline Price	from $233/mo	$188 first month, then $298/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want financing options and free lab work with their GLP-1 program	Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path
Watch out for	Promo-dependent pricing, standard tirzepatide is $449/mo without discount, nearly double the promo price	Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
Ranking	#39	#30
Get started	Visit Elevate Health	Visit Hers

Pros & Cons Compared

Elevate Health

Pros

+Oral semaglutide from $114/mo, one of the lowest prices for any form of semaglutide in the market
+Free blood work included with all GLP-1 programs for baseline health assessment and monitoring
+Buy-now-pay-later financing via Affirm, Klarna, and Afterpay, removes the upfront cost barrier
+Medications sourced from FDA-registered 503B outsourcing facilities, stricter oversight than standard compounding

Cons

−Promo-dependent pricing, standard tirzepatide is $449/mo without discount, nearly double the promo price
−Select state availability only, not available nationwide
−Trustpilot rating flagged for potential review solicitation, verify independently

Hers

Pros

+FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

−Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
−Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
−Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
−Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
−Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

Our Verdict

Hers edges out Elevate Health with a score of 7.3/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Elevate Health is from $233/mo; Hers is $188 first month, then $298/mo.